DiaMedica Therapeutics Inc
NASDAQ:DMAC
Income Statement
Earnings Waterfall
DiaMedica Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-21.3m
USD
|
Operating Income
|
-21.3m
USD
|
Other Expenses
|
1.9m
USD
|
Net Income
|
-19.4m
USD
|
Income Statement
DiaMedica Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(8)
|
(7)
|
(6)
|
(5)
|
(5)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(7)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(11)
|
(11)
|
(11)
|
(13)
|
(14)
|
(15)
|
(15)
|
(14)
|
(14)
|
(14)
|
(13)
|
(14)
|
(16)
|
(17)
|
(19)
|
(21)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
|
Research & Development |
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(7)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(9)
|
(8)
|
(8)
|
(7)
|
(8)
|
(9)
|
(10)
|
(12)
|
(13)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(8)
N/A
|
(7)
+9%
|
(6)
+14%
|
(5)
+12%
|
(5)
+9%
|
(3)
+28%
|
(3)
+26%
|
(2)
+28%
|
(1)
+22%
|
(1)
+5%
|
(2)
-15%
|
(2)
-49%
|
(2)
-5%
|
(3)
-37%
|
(4)
-16%
|
(4)
+6%
|
(5)
-22%
|
(5)
0%
|
(5)
-17%
|
(6)
-15%
|
(7)
-12%
|
(9)
-31%
|
(10)
-10%
|
(11)
-12%
|
(12)
-6%
|
(11)
+9%
|
(11)
+0%
|
(11)
-6%
|
(13)
-13%
|
(14)
-10%
|
(15)
-5%
|
(15)
-1%
|
(14)
+7%
|
(14)
+1%
|
(14)
+0%
|
(13)
+2%
|
(14)
-5%
|
(16)
-14%
|
(17)
-9%
|
(19)
-12%
|
(21)
-10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
Pre-Tax Income |
(8)
N/A
|
(7)
+10%
|
(6)
+14%
|
(6)
+7%
|
(5)
+9%
|
(3)
+31%
|
(3)
+24%
|
(2)
+25%
|
(2)
+19%
|
(1)
+7%
|
(2)
-12%
|
(2)
-42%
|
(2)
+6%
|
(3)
-43%
|
(4)
-17%
|
(4)
+1%
|
(4)
-16%
|
(4)
+15%
|
(4)
-18%
|
(5)
-10%
|
(6)
-20%
|
(8)
-46%
|
(9)
-9%
|
(10)
-12%
|
(11)
-5%
|
(10)
+8%
|
(10)
0%
|
(11)
-8%
|
(12)
-16%
|
(13)
-10%
|
(14)
-6%
|
(15)
-2%
|
(14)
+7%
|
(13)
+1%
|
(14)
-1%
|
(13)
+3%
|
(14)
-4%
|
(15)
-13%
|
(17)
-7%
|
(18)
-9%
|
(19)
-8%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(8)
|
(7)
|
(6)
|
(6)
|
(5)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(8)
|
(9)
|
(10)
|
(11)
|
(10)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(14)
|
(13)
|
(14)
|
(13)
|
(14)
|
(15)
|
(17)
|
(18)
|
(19)
|
|
Net Income (Common) |
(8)
N/A
|
(7)
+9%
|
(6)
+14%
|
(6)
+7%
|
(5)
+9%
|
(3)
+31%
|
(3)
+25%
|
(2)
+25%
|
(2)
+19%
|
(1)
+8%
|
(2)
-12%
|
(2)
-43%
|
(2)
+5%
|
(3)
-43%
|
(4)
-18%
|
(4)
+1%
|
(4)
-15%
|
(4)
+15%
|
(4)
-19%
|
(5)
-11%
|
(6)
-20%
|
(8)
-46%
|
(9)
-9%
|
(10)
-12%
|
(11)
-5%
|
(10)
+8%
|
(10)
N/A
|
(11)
-8%
|
(12)
-16%
|
(13)
-10%
|
(14)
-6%
|
(15)
-2%
|
(14)
+7%
|
(13)
+1%
|
(14)
-1%
|
(13)
+3%
|
(14)
-4%
|
(15)
-13%
|
(17)
-7%
|
(18)
-9%
|
(19)
-8%
|
|
EPS (Diluted) |
-2.73
N/A
|
-2.38
+13%
|
-1.98
+17%
|
-1.74
+12%
|
-1.67
+4%
|
-1.12
+33%
|
-0.75
+33%
|
-0.56
+25%
|
-0.44
+21%
|
-0.34
+23%
|
-0.37
-9%
|
-0.48
-30%
|
-0.47
+2%
|
-0.57
-21%
|
-0.62
-9%
|
-0.61
+2%
|
-0.72
-18%
|
-0.54
+25%
|
-0.54
N/A
|
-0.6
-11%
|
-0.74
-23%
|
-0.69
+7%
|
-0.75
-9%
|
-0.84
-12%
|
-0.89
-6%
|
-0.74
+17%
|
-0.69
+7%
|
-0.63
+9%
|
-0.78
-24%
|
-0.71
+9%
|
-0.77
-8%
|
-0.76
+1%
|
-0.65
+14%
|
-0.5
+23%
|
-0.51
-2%
|
-0.5
+2%
|
-0.52
-4%
|
-0.59
-13%
|
-0.62
-5%
|
-0.47
+24%
|
-0.6
-28%
|